Viral infections and systemic lupus erythematosus: new players in an old story

M Quaglia, G Merlotti, M De Andrea, C Borgogna… - Viruses, 2021 - mdpi.com
… which regulates the surface expression of CD4 on … TCRζ, have been associated with T cell
activation upon TCR stimulation. Similar to HERV-E clone 4-1, also HRES-1/Rab4 expression

Harnessing the natural biology of adeno-associated virus to enhance the efficacy of cancer gene therapy

JJ Bower, L Song, P Bastola, ML Hirsch - Viruses, 2021 - mdpi.com
… /or miRs expressed in rAAV may be an excellent alternative to … patients, but almost always
ultimately result in acquired resistance. rAAV’s ability to provide long-term genetic expression

Potential strategies against resistance to CAR T-cell therapy in haematological malignancies

Q Cai, M Zhang, Z Li - Therapeutic Advances in Medical …, 2020 - journals.sagepub.com
… additionally armored with genes that enable, for example, the expression of cytokines. …
alternative splicing occurred with rare frequency. Therefore, acquired mutations and alternative

Building on synthetic immunology and T cell engineering: a brief journey through the history of chimeric antigen receptors

H Abken - Human Gene Therapy, 2021 - liebertpub.com
… of recurrent chronic myeloid leukemia 26 in patients after allogeneic … (EBV)-associated
posttransplant lymphoproliferative disease … The alternatives to viral gene transfer technologies are …

Multispecific CAR T cells deprive lymphomas of escape via antigen loss

F Furqan, NN Shah - Annual Review of Medicine, 2023 - annualreviews.org
alternative exon splicing or point mutations, which, although well described in B-ALL,
have not been reported to alter the expression … Although the factors associated with CD19-negative …

The therapeutic potential of targeting tryptophan catabolism in cancer

CA Opitz, LF Somarribas Patterson… - British journal of …, 2020 - nature.com
… Finally, alternative approaches are suggested to circumvent these problems. … of anergy,
84 as well as downregulation of the TCRζ chain, which impairs the cytotoxic effector function of …

T cell engaging immunotherapies, highlighting chimeric antigen receptor (CAR) T cell therapy

E De Bousser, N Callewaert, N Festjens - Cancers, 2021 - mdpi.com
leukemia (ALL) and for the treatment of patients experiencing minimal residual disease (MRD)
[30]. Its efficiency in the treatment of acute myeloid leukemia (… CARs with alternative co-…

PHF6 as a novel interactor of the transcriptional co-regulator LMO2 in T-Cell acute lymphoblastic leukaemia (T-ALL) and myeloid differentiation

S Binhassan - 2020 - etheses.bham.ac.uk
Genetic abnormalities that trigger the aberrant expression of LMO2 and other members of
… DNA and regulates gene expression. Importantly, we identified many genes of transcription …

Lipopolymer Mediated SiRNA Therapy in Acute Lymphoblastic Leukemia

M Mohseni - 2021 - era.library.ualberta.ca
… inhibition of target gene to achieve functional outcomes that could be potentially applied as
an alternative therapeutic approach … and acute myeloid leukemias) for therapeutic purposes. …

CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application

EP Minina, DV Dianov, SA Sheetikov… - Biochemistry …, 2024 - Springer
… Preclinical studies have shown that many alternative immune CAR cells with a high … I trials
in patients with relapsed or resistant acute myeloid leukemia. Additional expression of a CAR …